Loading organizations...
Utrecht Holdings functions as the Knowledge Transfer Office for Utrecht University and the University Medical Center Utrecht. It specializes in bringing research innovations to market by providing comprehensive support across business development, intellectual property, finance, and legal affairs. The organization facilitates the creation of new products and services from academic research, acting as a pivotal link between university-generated science and societal application.
Established in 1998, Utrecht Holdings was founded on the insight that groundbreaking scientific research conducted at its parent institutions held significant potential for broader societal and economic impact. The entity was created by Utrecht University and UMC Utrecht to systematically transfer knowledge and inventions from their laboratories to practical use, leveraging the deep scientific expertise within these academic environments.
Utrecht Holdings serves researchers from its affiliated institutions, along with industrial partners and investors keen on commercializing scientific discoveries. Its overarching vision is to translate academic excellence into tangible benefits for society, supporting ventures that advance patient care, develop novel therapies, and contribute to sustainability efforts, thereby making a lasting difference.
Utrecht Holdings has 2 tracked investments across 2 companies. The latest tracked deal is $4.0M Series A Extension in Synerkine Pharma in December 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 16, 2021 | Synerkine Pharma | $4.0M Series A Extension | TED Fjällman | Thuja Capital |
| Mar 29, 2016 | Gadeta | $7.8M Series A | Geeta Vemuri, Giovanni Mariggi | — |